A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)
Clinical trial NCT06698016 · COMPLETED
Trial details
- NCT number
- NCT06698016
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2023-10-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.